Stage II Soft Tissue Sarcoma AJCC v7

general

Stage II is divided into stages IIA and IIB. In stage IIA, the tumor is mid-grade (somewhat likely to grow and spread quickly) or high-grade (likely to grow and spread quickly) and 5 centimeters or smaller. It may be either superficial (in subcutaneous tissue with no spread into connective tissue or muscle below) or deep (in the muscle and may be in connective or subcutaneous tissue).

67

Centers

80

Active Trials

$12.8B

Cancer Funding

Specific Cancer Types(1)

NameCenters
Stage IB Soft Tissue Sarcoma AJCC v767

Top Centers for Stage II Soft Tissue Sarcoma AJCC v7(67)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
53.8
2
NCI Comprehensive
Active Research Program
53.8
3
NCI Comprehensive
Active Research Program
53.8
4
NCI Comprehensive
Active Research Program
53.8
553.8
6
NCI Comprehensive
Active Research Program
53.8
7
NCI Comprehensive
Active Research Program
53.8
8
NCI Comprehensive
Active Research Program
53.8
9
NCI Clinical
Active Research Program
53.8
10
NCI Comprehensive
Active Research Program
53.8
11
NCI Comprehensive
Active Research Program
53.8
12
Active Research Program
53.8
13
Active Research Program
53.8
14
NCI Comprehensive
15
16
NCI Comprehensive
17
NCI Comprehensive
18
NCI Comprehensive
19
NCI Comprehensive
20
21
22
NCI Comprehensive
23
NCI Comprehensive
24
25
26
NCI Comprehensive
27
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
28
29
NCI Comprehensive
30
NCI Comprehensive
31
NCI Comprehensive
32
NCI Comprehensive
33
NCI Clinical
34
35
NCI Comprehensive
36
NCI Comprehensive
37
NCI Comprehensive
38
39
Cedars-Sinai CancerLos Angeles, CA
40
41
42
NCI Comprehensive
43
44
45
46
NCI Comprehensive
47
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
48
49
50
51
52
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
53
54
NCI Comprehensive
55
56
57
58
59
60
61
62
63
64
65
66
BC CancerVancouver, BC
67

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →